Impact of diabetes on cardiovascular risk in patients with dyslipidemia

被引:0
|
作者
Pena-Rodriguez, Gregorio [1 ]
Gallardo-Hernandez, Ana G. [2 ]
Llerena-Garcia, Cindy G. [1 ]
Maldonado-Burgos, Martha A. [3 ]
Escobedo-Naurisa, Eloisa [1 ]
机构
[1] Inst Mexicano Seguro Social, Unidad Med Familiar 48, Med Familiar, Ciudad Juarez, Chih, Mexico
[2] Inst Mexicano Seguro Social, Unidad Invest Med Enfermedades Metab, Siglo 21, Coordinac Invest, Mexico City, Mexico
[3] Inst Mexicano Seguro Social, Coordinac Planeac & Enlace Inst, Chihuahua, Chih, Mexico
来源
ARCHIVOS DE CARDIOLOGIA DE MEXICO | 2024年 / 94卷 / 02期
关键词
Dyslipidemia; Cardiovascular risk; Diabetes;
D O I
10.24875/ACM.23000042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the impact of diabetes on cardiovascular risk in patients with dyslipidemia. Method: Observational, cross-sectional and comparative study in which cardiovascular risk was determined at 10 years in 100 patients with dyslipidemia, of these, 50 non-diabetic patients and 50 diabetic patients. Results: Both groups had similar characteristics in terms of age, blood pressure figures, average body mass index, and HDL and LDL levels. It was observed that the diabetic group has almost double the risk compared to the dyslipidemia group, 13.7 vs. 7.9 (p = 0.014), and the calculated heart age is also higher in patients with diabetes, 80 vs. 66 years (p = 0.003). Even in patients with diabetes there is a greater difference between the real age and the age of the heart, 24 years vs. 15 years of patients without diabetes (p = 0.000). Conclusion: Having diabetes and dyslipidemia doubles the cardiovascular risk of patients. Little metabolic control was found in the population studied, which significantly increases complications at an early age and the economic burden on the health system and the families of patients, so it is necessary to rethink treatment strategies to improve metabolic control and with it the prognosis for the patient in the long term.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 50 条
  • [1] Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia
    Ali, Yasmine S.
    Linton, MacRae F.
    Fazio, Sergio
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2008, 15 (02) : 142 - 146
  • [2] Impact of dyslipidemia on cardiovascular risk
    Chiluisa Mancheno, Anthony Ricardo
    Fiallos Reinoso, Maria Jose
    Gonzalez Villacreces, Valeria Alexandra
    Estrella Camacho, Pablo Cesar
    Pineda Narvaez, Roberth Santiago
    Vazquez Verdugo, Maria Patricia
    Roblez Arias, Jorge Luis
    Jaramillo Martinez, Carolina Salome
    Carrillo Bravo, Kevin Daniel
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2023, 18 (01): : 31 - 34
  • [3] Reducing cardiovascular risk in patients with type 2 diabetes: Management of dyslipidemia
    Hilleman, DE
    FORMULARY, 2003, 38 (08) : 478 - +
  • [4] Reducing cardiovascular risk in patients with type 2 diabetes: management of dyslipidemia
    Campbell, Jennifer
    Hilleman, Daniel
    FORMULARY, 2010, 45 (04) : 124 - 134
  • [5] Dyslipidemia and cardiovascular risk in type 2 diabetes
    Oulahiane, A.
    El Haddad, N.
    El Mazouni, Z.
    Iraqi, H.
    Gharbi, M. -H.
    Chraibi, A.
    DIABETES & METABOLISM, 2011, 37 : A78 - A78
  • [6] DYSLIPIDEMIA, POLYMORPHIC GENETIC MARKERS AND CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES
    Bystrova, A.
    Krasilnikova, E.
    Voitovich, A.
    Larionova, V.
    Baranova, E.
    Shlyakhto, E.
    JOURNAL OF HYPERTENSION, 2010, 28 : E292 - E292
  • [7] Honey and Cardiovascular Risk Factors, in Normal Individuals and in Patients with Diabetes Mellitus or Dyslipidemia
    Al-Waili, Noori
    Salom, Khelod
    Al-Ghamdi, Ahmad
    Ansari, Mohammad Javed
    Al-Waili, Ali
    Al-Waili, Thia
    JOURNAL OF MEDICINAL FOOD, 2013, 16 (12) : 1063 - 1078
  • [8] Increased risk of cardiovascular events among type 2 diabetes patients with dyslipidemia
    Blonde, Lawrence
    Fox, Kathleen M.
    Ohsfeldt, Robert L.
    Parikh, Shamik
    Grandy, Susan
    CIRCULATION, 2007, 115 (08) : E230 - E230
  • [9] DYSLIPIDEMIA AND CARDIOVASCULAR RISK FACTORS IN A SAMPLE OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Guerra Ruiz, A. R.
    Lavin Gomez, B. A.
    Garcia Unzueta, M. T.
    Hernandez Hernandez, L. A.
    Vazquez Salvi, L. A.
    Vazquez de Prada, J. A.
    Garrido Gomez, J. C.
    ATHEROSCLEROSIS, 2018, 275 : E217 - E217
  • [10] Impact of a clinical pathway on cardiovascular risk in patients with diabetes
    Concepcion Fernandez-Planelles, Maria
    Palazon-Bru, Antonio
    Calvo-Perez, Miriam
    Miguel Pico-Alfonso, Antonio
    Francisco Gil-Guillen, Vicente
    POSTGRADUATE MEDICINE, 2022, 134 (01) : 96 - 103